Good afternoon :)
$
₹
M

MiniMed Group, Inc. Common Stock

MMED

NASDAQ
M

MiniMed Group, Inc. Common Stock

MMED

NASDAQ
$19.292.33% (+0.44)
$
₹
$19.292.33% (+0.44)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Medical Instruments & Supplies

Mid Cap

With a market cap of $5.3B the stock is ranked 1408

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

—
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

1.42
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$-1.53
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

—
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

-9.74%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Analyst Ratings & Forecast

Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 

Based on 16 analysts reports

Buy
12 analysts
Hold
3 analysts
Sell
1 analyst

Price Upside

+32.02%

Earnings Growth

+233.4%

Rev. Growth

+10.76%

See Detailed Forecast

Company Profile

Company Profile

MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, such as insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform includes Automated Insulin Delivery (AID) systems for glucose sensing and automated insulin dosing and administration for glycemic control and Smart Multiple Daily Injection (MDI) systems for self-administering insulin by manual injections, which include InPen, Simplera Sync, or Guardian 4 sensor, and wraparound applications and services. It also offers CareLink, a software platform that provides support for person with diabetes, their caretakers, and HCPS. MiniMed Group, Inc. was founded in 1983 and is headquartered in Northridge, California.
MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, such as insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform includes Automated Insulin Delivery (AID) systems for glucose sensing and automated insulin dosing and administration for glycemic control and Smart Multiple Daily Injection (MDI) systems for self-administering insulin by manual injections, which include InPen, Simplera Sync, or Guardian 4 sensor, and wraparound applications and services. It also offers CareLink, a software platform that provides support for person with diabetes, their caretakers, and HCPS. MiniMed Group, Inc. was founded in 1983 and is headquartered in Northridge, California.

Peers

Compare with peers Compare with peers 

Peers

Compare with peers Compare with peers 
Medline Inc. Class A Common Stock
MDLN
M
P/E Ratio
80.07
80.07
1Y Return
1.58%
1.58%
Buy Reco %
85.18
85.18
West Pharmaceutical Services Inc
WST
West Pharmaceutical Services Inc
P/E Ratio
45.77
45.77
1Y Return
42.57%
42.57%
Buy Reco %
93.75
93.75
The Cooper Companies, Inc
COO
The Cooper Companies, Inc
P/E Ratio
21.06
21.06
1Y Return
11.94%
11.94%
Buy Reco %
35.29
35.29
Align Technology Inc
ALGN
Align Technology Inc
P/E Ratio
22.46
22.46
1Y Return
11.72%
11.72%
Buy Reco %
50.00
50.00
Bausch + Lomb Corp
BLCO
Bausch + Lomb Corp
P/E Ratio
—
—
1Y Return
33.53%
33.53%
Buy Reco %
46.66
46.66
Compare with Peers

Forecast

Forecast

Price

Revenue

Earnings

Price Forecast

Price Forecast

2026
Current$19.29Baseline
Analyst Target - 1 year
Target$25.47+32.02%

All values in $

20232024202520262027$20.02$22.69$25.35Target+32.02%
2026
Current$19.29Baseline
Analyst Target - 1 year
Target$25.47+32.02%

All values in $

Revenue Forecast

Revenue Forecast

Lower revenue growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 10.76% growth, versus a trailing 3-year CAGR of 11.38%.

2026
Current$3.10Baseline
Forecast for Apr 2027
High$3.46+11.65%
Average$3.43+10.76%
Low$3.42+10.44%

All values in $ Billion

202320242025202620272.242.462.713.10Low+10.44%Average+10.76%High+11.65%
2026
Current$3.10Baseline
Forecast for Apr 2027
High$3.46+11.65%
Average$3.43+10.76%
Low$3.42+10.44%

All values in $ Billion

Earnings Per Share Forecast

Earnings Per Share Forecast

2026
Current$-0.52Baseline
Forecast for Apr 2027
High$0.77+245.92%
Average$0.7+233.4%
Low$0.62+218.14%

All values in $

20232024202520262027N/AN/AN/A-0.52Low+218.14%Average+233.4%High+245.92%
2026
Current$-0.52Baseline
Forecast for Apr 2027
High$0.77+245.92%
Average$0.7+233.4%
Low$0.62+218.14%

All values in $

Financials

Financials

Income

Balance Sheet

Cash Flow

752
-27
790
-119
837
-183
843
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Revenue
Net Income
Financial YearQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
Total Revenue687724723752790837843
Net Income-10-209-19-27-119-1830
Net Profit Margin-1.45%-28.86%-2.62%-3.59%-15.06%-21.86%0%
See CostsAll values in $ Million

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareMedical Instruments & Supplies

Valuation

Returns

Forecast

ScreenerCompare valuation on Screener
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
MiniMed Group, Inc. Common Stock -1.42-
Medline Inc. Class A Common Stock80.072.43-
West Pharmaceutical Services Inc45.779.683.21
ScreenerCompare valuation on Screener

Price Comparison

Price Comparison

Compare MMED with any stock or ETF
Compare MMED with any stock or ETF
Comparing from
MMED
MDLN
WST
Loading...

Frequently asked questions

  1. MiniMed Group, Inc. Common Stock (MMED) share price today is $19.29 as of November 5, 2026 at 2:29 AM IST. The stock touched a day high of $19.90 and a day low of $19.29.

  2. MiniMed Group, Inc. Common Stock stock trades on NASDAQ under the ticker symbol MMED.

  3. MiniMed Group, Inc. Common Stock's market capitalization is $5.31B as of November 5, 2026 at 2:29 AM IST.

  4. MiniMed Group, Inc. Common Stock's price-to-earnings (P/E) ratio is N/A as of November 4, 2026.

  5. MiniMed Group, Inc. Common Stock's price-to-book (P/B) ratio is 1.42 as of November 4, 2026.

  6. Yes, You can buy MiniMed Group, Inc. Common Stock shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy MiniMed Group, Inc. Common Stock shares in three steps: 1. Search MiniMed Group, Inc. Common Stock on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since MiniMed Group, Inc. Common Stock trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in MiniMed Group, Inc. Common Stock (MMED) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.5183 shares at the current price of $19.29.

Loading...